Streetbeat News

Products Services

AXDX

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has received FDA clearance for its Accelerate Arc system, an automated platform for rapid microbial identification, enhancing the fight against sepsis and antimicrobial resistance.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:16 pm

CLSK

MARA

RIOT

Bitcoin mining stocks Marathon Digital, Riot Platforms, and CleanSpark are declining as Bitcoin's price drops by 2.5%. Despite recent gains, Bitcoin miners are expected to report September metrics this week. Marathon, Riot, and CleanSpark's stocks are down 3.76%, 3.44%, and 4.74% respectively.

Portfolio Pulse from Adam Eckert

September 30, 2024 | 1:15 pm

SYNX

Silynxcom Ltd. (NYSE:SYNX) has announced $740,000 in new orders from the Israel Defense Forces for tactical communication equipment, bringing total orders from the IDF to approximately $1,550,000 since July 2024. This indicates growth in the military tactical communication market.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:13 pm

KEY

KeyBank has surpassed $1 million in Neighbors First Credits, aiding 200 clients in achieving sustainable and affordable homeownership since the program's launch in July 2023.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:08 pm

MNOV

MediciNova, Inc. (NASDAQ:MNOV) has announced a $22 million grant from the NIH to evaluate the efficacy of MN-166 in treating ALS through an Expanded Access Protocol. This trial will provide access to the drug for ALS patients not eligible for the COMBAT-ALS trial.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:05 pm

RTX

Raytheon, an RTX business, has secured a $525 million contract from the U.S. Navy to produce ESSM Block 2 missiles and spares for the U.S. and allied nations, enhancing naval capabilities.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 1:04 pm

ABBV

ACN

DIS

META

On CNBC's 'Final Trades', analysts discussed Meta, Accenture, AbbVie, and Disney. Meta received a price target increase, Accenture reported strong earnings, AbbVie shared positive trial results, and Disney is expected to see higher streaming profitability despite layoffs.

Portfolio Pulse from Avi Kapoor

September 30, 2024 | 12:43 pm

CINT

CI&T (NYSE:CINT) has achieved AWS Well-Architected Authorized Partner status, highlighting its expertise in designing and managing secure applications using AWS best practices. This status differentiates CI&T as an AWS Advanced Consulting Partner with specialized proficiency.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:40 pm

BMY

PRME

Prime Medicine Inc. has entered a strategic collaboration with Bristol Myers Squibb to develop next-generation ex vivo T-cell therapies, potentially worth over $3.5 billion. Prime Medicine will receive $110 million upfront and focus on developing treatments for chronic granulomatous disease and other conditions.

Portfolio Pulse from Vandana Singh

September 30, 2024 | 12:38 pm